Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amneal Pharmaceuticals has received FDA approval to manufacture bethanechol chloride tablets, in strengths of 5mg, 10mg, 25mg and 50 mg for the treatment of urinary incontinence.
Subscribe to our email newsletter
Bethanechol chloride is an AA-rated, therapeutically equivalent alternative to Urecholine, a trademark drug of Barr Laboratories.
Amneal will begin shipping bethanechol in the 25mg strength as of January 4, 2008 with the other three strengths beginning in February 2008. Amneal’s bethanechol is expected to be available through wholesalers-distributors as well as directly to customers.